Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep | 15 | 2025 | 36 | 3.710 |
Why?
|
| Sleep Wake Disorders | 6 | 2023 | 10 | 2.840 |
Why?
|
| Circadian Rhythm | 11 | 2023 | 31 | 2.610 |
Why?
|
| Melatonin | 3 | 2022 | 3 | 1.600 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2023 | 7 | 1.390 |
Why?
|
| Light | 4 | 2018 | 12 | 1.230 |
Why?
|
| Disorders of Excessive Somnolence | 3 | 2023 | 3 | 1.180 |
Why?
|
| Motor Vehicles | 4 | 2022 | 5 | 1.170 |
Why?
|
| Rural Population | 4 | 2025 | 654 | 1.160 |
Why?
|
| Humans | 38 | 2025 | 14537 | 1.110 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2023 | 2 | 1.080 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2021 | 3 | 0.990 |
Why?
|
| Depression | 4 | 2025 | 121 | 0.970 |
Why?
|
| Actigraphy | 1 | 2025 | 3 | 0.970 |
Why?
|
| Quality of Life | 5 | 2023 | 177 | 0.930 |
Why?
|
| Aldosterone | 1 | 2023 | 12 | 0.900 |
Why?
|
| Academies and Institutes | 1 | 2023 | 6 | 0.880 |
Why?
|
| Appetite | 1 | 2023 | 1 | 0.870 |
Why?
|
| HIV Infections | 7 | 2025 | 5097 | 0.850 |
Why?
|
| Middle Aged | 18 | 2025 | 3601 | 0.820 |
Why?
|
| Urban Population | 1 | 2025 | 257 | 0.820 |
Why?
|
| Male | 23 | 2025 | 6754 | 0.820 |
Why?
|
| Overweight | 1 | 2023 | 87 | 0.800 |
Why?
|
| Female | 24 | 2025 | 9103 | 0.790 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 103 | 0.770 |
Why?
|
| Aged | 12 | 2022 | 1740 | 0.740 |
Why?
|
| Hypertension | 2 | 2021 | 419 | 0.660 |
Why?
|
| Exercise | 4 | 2023 | 205 | 0.640 |
Why?
|
| Developing Countries | 1 | 2021 | 400 | 0.620 |
Why?
|
| Adult | 22 | 2025 | 5913 | 0.620 |
Why?
|
| Phototherapy | 1 | 2018 | 6 | 0.610 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 237 | 0.610 |
Why?
|
| Cognition | 2 | 2018 | 75 | 0.600 |
Why?
|
| Young Adult | 10 | 2025 | 2498 | 0.590 |
Why?
|
| Pain | 1 | 2018 | 41 | 0.590 |
Why?
|
| Adolescent | 9 | 2025 | 2985 | 0.550 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 563 | 0.530 |
Why?
|
| Cross-Sectional Studies | 10 | 2025 | 1422 | 0.520 |
Why?
|
| Aging | 3 | 2023 | 109 | 0.500 |
Why?
|
| Nigeria | 2 | 2025 | 49 | 0.460 |
Why?
|
| South Africa | 13 | 2025 | 7596 | 0.390 |
Why?
|
| Urologic Diseases | 1 | 2011 | 1 | 0.370 |
Why?
|
| Risk Factors | 8 | 2024 | 1475 | 0.370 |
Why?
|
| Automobile Driving | 2 | 2020 | 3 | 0.350 |
Why?
|
| Occupational Diseases | 2 | 2020 | 40 | 0.330 |
Why?
|
| Health Status | 2 | 2020 | 111 | 0.330 |
Why?
|
| Attention | 2 | 2018 | 5 | 0.250 |
Why?
|
| Wakefulness | 2 | 2018 | 2 | 0.240 |
Why?
|
| Lighting | 2 | 2018 | 3 | 0.240 |
Why?
|
| Anxiety | 2 | 2021 | 40 | 0.240 |
Why?
|
| Schools | 1 | 2025 | 73 | 0.230 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 468 | 0.230 |
Why?
|
| Vasopressins | 1 | 2023 | 1 | 0.230 |
Why?
|
| Nocturia | 2 | 2016 | 2 | 0.220 |
Why?
|
| Review Literature as Topic | 1 | 2023 | 6 | 0.220 |
Why?
|
| Adolescent Health | 1 | 2023 | 15 | 0.220 |
Why?
|
| Energy Intake | 1 | 2023 | 24 | 0.220 |
Why?
|
| Shift Work Schedule | 1 | 2022 | 1 | 0.200 |
Why?
|
| Uganda | 1 | 2022 | 197 | 0.200 |
Why?
|
| Animals | 2 | 2023 | 1081 | 0.200 |
Why?
|
| Africa | 1 | 2023 | 376 | 0.200 |
Why?
|
| Prevalence | 2 | 2023 | 1192 | 0.200 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 217 | 0.190 |
Why?
|
| Polysomnography | 1 | 2021 | 1 | 0.190 |
Why?
|
| Psychometrics | 1 | 2021 | 22 | 0.190 |
Why?
|
| Income | 1 | 2021 | 85 | 0.190 |
Why?
|
| Students | 1 | 2021 | 50 | 0.190 |
Why?
|
| Waist Circumference | 1 | 2021 | 60 | 0.190 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 435 | 0.190 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 146 | 0.180 |
Why?
|
| Occupational Stress | 1 | 2020 | 1 | 0.180 |
Why?
|
| Chronic Pain | 1 | 2020 | 3 | 0.180 |
Why?
|
| Leisure Activities | 1 | 2020 | 9 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2022 | 100 | 0.180 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 265 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2019 | 175 | 0.180 |
Why?
|
| Isoantibodies | 1 | 2020 | 15 | 0.180 |
Why?
|
| Autoantibodies | 1 | 2020 | 49 | 0.170 |
Why?
|
| Child | 2 | 2023 | 2242 | 0.170 |
Why?
|
| HIV | 1 | 2022 | 380 | 0.170 |
Why?
|
| HLA Antigens | 1 | 2020 | 50 | 0.170 |
Why?
|
| Obesity | 1 | 2023 | 367 | 0.170 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 64 | 0.170 |
Why?
|
| Period Circadian Proteins | 1 | 2019 | 1 | 0.160 |
Why?
|
| Circadian Clocks | 1 | 2019 | 1 | 0.160 |
Why?
|
| Photic Stimulation | 1 | 2018 | 2 | 0.160 |
Why?
|
| Color Therapy | 1 | 2018 | 1 | 0.150 |
Why?
|
| Color | 1 | 2018 | 2 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 7 | 0.150 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2016 | 1 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 656 | 0.130 |
Why?
|
| Anti-Retroviral Agents | 1 | 2019 | 551 | 0.120 |
Why?
|
| Pregnancy | 1 | 2020 | 1862 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2020 | 321 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 139 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2025 | 967 | 0.090 |
Why?
|
| Time Factors | 2 | 2010 | 507 | 0.090 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2022 | 108 | 0.090 |
Why?
|
| Biological Clocks | 1 | 2010 | 1 | 0.090 |
Why?
|
| Reaction Time | 1 | 2009 | 1 | 0.080 |
Why?
|
| Sleep Deprivation | 1 | 2009 | 1 | 0.080 |
Why?
|
| Chronobiology Disorders | 1 | 2009 | 1 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 5 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2023 | 107 | 0.080 |
Why?
|
| Age Factors | 1 | 2010 | 370 | 0.080 |
Why?
|
| Phenotype | 2 | 2019 | 158 | 0.070 |
Why?
|
| Alleles | 2 | 2019 | 143 | 0.070 |
Why?
|
| Hyperhomocysteinemia | 1 | 2006 | 2 | 0.070 |
Why?
|
| Anemia, Pernicious | 1 | 2006 | 2 | 0.070 |
Why?
|
| Thrombosis | 1 | 2006 | 47 | 0.070 |
Why?
|
| Blood Preservation | 1 | 2004 | 3 | 0.060 |
Why?
|
| Plasma | 1 | 2004 | 39 | 0.060 |
Why?
|
| Temperature | 1 | 2004 | 56 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2024 | 111 | 0.050 |
Why?
|
| Lipids | 1 | 2023 | 81 | 0.050 |
Why?
|
| Quarantine | 1 | 2021 | 5 | 0.050 |
Why?
|
| Cytokines | 1 | 2021 | 107 | 0.050 |
Why?
|
| Life Style | 1 | 2021 | 86 | 0.050 |
Why?
|
| Placental Circulation | 1 | 2020 | 6 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 18 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 101 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2020 | 22 | 0.040 |
Why?
|
| Weight Loss | 1 | 2020 | 12 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2023 | 799 | 0.040 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2020 | 40 | 0.040 |
Why?
|
| Epitopes | 1 | 2020 | 97 | 0.040 |
Why?
|
| Glucose | 1 | 2019 | 45 | 0.040 |
Why?
|
| Mental Health | 1 | 2001 | 91 | 0.040 |
Why?
|
| Cholesterol | 1 | 2019 | 38 | 0.040 |
Why?
|
| Health Surveys | 1 | 2019 | 59 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 370 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 296 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 411 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 198 | 0.040 |
Why?
|
| Genotype | 1 | 2019 | 442 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2020 | 1160 | 0.040 |
Why?
|
| Fasting | 1 | 2016 | 16 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2020 | 1479 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 2244 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 253 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2011 | 1 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2011 | 1 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 9 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 46 | 0.020 |
Why?
|
| Chronobiology Phenomena | 1 | 2009 | 1 | 0.020 |
Why?
|
| Mathematics | 1 | 2009 | 3 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2009 | 12 | 0.020 |
Why?
|
| Homocysteine | 1 | 2006 | 1 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2006 | 4 | 0.020 |
Why?
|
| Homozygote | 1 | 2006 | 61 | 0.020 |
Why?
|
| Dimerization | 1 | 2004 | 4 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 2004 | 13 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2004 | 10 | 0.010 |
Why?
|
| Thromboplastin | 1 | 2004 | 9 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2004 | 12 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 2004 | 15 | 0.010 |
Why?
|
| Freezing | 1 | 2004 | 6 | 0.010 |
Why?
|
| France | 1 | 2001 | 5 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2001 | 27 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2001 | 480 | 0.010 |
Why?
|